<unk>  (also known as Red market) is the<unk> ng of human<unk> s, tissues, or other body products, usually for transplantation. According to the World Health<unk> ization (WHO),<unk>  is a commercial transplantation where there is a profit, or transplantations that occur outside of national medical systems. There is a global need or demand for healthy body parts for transplantation, which exceeds the numbers available. , there are more than 100,000 candidates waiting for<unk>  transplant in the United States. The median wait time for heart and liver transplants in the U.S. between 2003 and 2014, was approximately 148 days. Average time waiting for donor<unk> s varies significantly depending on the patients UNOS status. Patients listed as Heart Status A1 wait an average of 73 days. There is a worldwide shortage of<unk> s available for transplantation, yet the commercial<unk>  of human<unk> s is illegal in all countries except Iran. Despite these prohibitions,<unk>  trafficking and transplant tourism remain widespread (however, the data on the extent of the black market<unk>  in<unk> s is difficult to obtain). The question of whether to legalize and regulate the<unk>  to combat illegal trafficking and<unk>  shortage is greatly debated. This discussion typically centers on the sale of kidneys by living donors, since human beings are born with two kidneys but need only one to survive.
Organ trade
Pharmaceutical marketing
Assistive technology
Wet market
Bioprocess
Chemical nomenclature
Regulatory science
Drug packaging